These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9629568)

  • 21. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
    King GR; Ellinwood EH; Silvia C; Joyner CM; Xue Z; Caron MG; Lee TH
    J Pharmacol Exp Ther; 1994 May; 269(2):743-9. PubMed ID: 8182540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY; Martin-Iverson MT
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain.
    Young LT; Wong DF; Goldman S; Minkin E; Chen C; Matsumura K; Scheffel U; Wagner HN
    Synapse; 1991 Nov; 9(3):188-94. PubMed ID: 1776131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered activity of midbrain dopamine neurons following 7-day withdrawal from chronic cocaine abuse is normalized by D2 receptor stimulation during the early withdrawal phase.
    Lee TH; Gao WY; Davidson C; Ellinwood EH
    Neuropsychopharmacology; 1999 Jul; 21(1):127-36. PubMed ID: 10379527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic escalating cocaine exposure, abstinence/withdrawal, and chronic re-exposure: effects on striatal dopamine and opioid systems in C57BL/6J mice.
    Zhang Y; Schlussman SD; Rabkin J; Butelman ER; Ho A; Kreek MJ
    Neuropharmacology; 2013 Apr; 67():259-66. PubMed ID: 23164614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
    Ginovart N; Lundin A; Farde L; Halldin C; Bäckman L; Swahn CG; Pauli S; Sedvall G
    Brain; 1997 Mar; 120 ( Pt 3)():503-14. PubMed ID: 9126061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of pertussis toxin on behavioral responses during different withdrawal periods from chronic cocaine treatment.
    Ushijima I; Mizuki Y; Kobayashi T; Aoki T; Suetsugi M; Usami K; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1369-77. PubMed ID: 11125860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of in vivo D-2 dopamine receptor binding of IBZM and NMSP in rat brain.
    Kung HF; Billings JJ; Guo YZ; Mach RH
    Int J Rad Appl Instrum B; 1988; 15(2):203-8. PubMed ID: 2966783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
    Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
    Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor autoradiography with 11C and [3H]-labelled ligands visualized by imaging plates.
    Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T
    Neuroreport; 1992 Nov; 3(11):961-4. PubMed ID: 1362360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of rolipram on in vivo dopamine receptor binding.
    Hosoi R; Ishikawa M; Kobayashi K; Gee A; Yamaguchi M; Inoue O
    J Neural Transm (Vienna); 2002 Sep; 109(9):1139-49. PubMed ID: 12203041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
    Ginovart N; Farde L; Halldin C; Swahn CG
    Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey.
    Onoe H; Inoue O; Suzuki K; Tsukada H; Itoh T; Mataga N; Watanabe Y
    Brain Res; 1994 Nov; 663(2):191-8. PubMed ID: 7874501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET imaging studies of dopamine D2 receptors: comparison of [18F]N-methylspiperone and the benzamide analogues [18F]MABN and [18F]MBP in baboon brain.
    Mach RH; Ehrenkaufer RL; Greenberg JH; Shao L; Morton TE; Evora PH; Nowak PA; Luedtke RR; Cohen D; Reivich M
    Synapse; 1995 Mar; 19(3):177-87. PubMed ID: 7784958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of three PET dopamine D2-like receptor ligands, [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone, in rats.
    Ishiwata K; Hayakawa N; Ogi N; Oda K; Toyama H; Endo K; Tanaka A; Senda M
    Ann Nucl Med; 1999 Jun; 13(3):161-7. PubMed ID: 10435376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in the dopaminergic receptor system after chronic administration of cocaine.
    Alburges ME; Narang N; Wamsley JK
    Synapse; 1993 Aug; 14(4):314-23. PubMed ID: 8161369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different times of withdrawal from cocaine administration cause changes in muscarinic and dopaminergic receptors in rat premotor cortex.
    Macêdo DS; Sousa FC; Vasconcelos SM; Lima VT; Viana GS
    Neurosci Lett; 2001 Oct; 312(3):129-32. PubMed ID: 11602327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of specific in vivo labeling of neuroleptic binding sites with 3-N-[11C]methylspiperone.
    Yanai K; Ido T; Ishiwata K; Hatazawa J; Watanuki S; Takahashi T; Ujiie A; Ito M; Matsuzawa T
    Eur J Nucl Med; 1986; 11(11):438-43. PubMed ID: 3486764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.